Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
198481-33-3
Purity
95%
Bazedoxifene is an indole derivative and third-generation selective estrogen receptor modulator (SERM) with potential antineoplastic activity. It is used to treat moderate to severe vasomotor symptoms in menopause and osteoporosis alone or in combination with conjugated estrogens.
Properties
Name
Bazedoxifene acetate
Smiles
CC(=O)O.CC1=C(C=2C=CC(O)=CC2)N(CC=3C=CC(OCCN4CCCCCC4)=CC3)C=5C=CC(O)=CC15
Targets
Please log in to see this information
Sold for research purposes under agreement from Pfizer Inc.
Bazedoxifene acetate is a selective estrogen receptor modulator widely used in endocrine and oncology research. Also known as PF-05208749, this compound is identified under CAS 198481-33-3 or 198481-33-3 and is associated with modulation of estrogen receptor signaling in various biological systems. Bazedoxifene acetate Pfizer development programs contributed to its recognition as a reference molecule for studying hormone-related pathways and receptor selectivity.
Researchers often evaluate Bazedoxifene acetate chemical structure to understand how the compound interacts with estrogen receptor subtypes and influences receptor conformation. In addition, Bazedoxifene acetate molecular weight is an important parameter in experimental design, ensuring accurate compound preparation and reproducibility in both in vitro and in vivo studies.
Application Bazedoxifene acetate is primarily focused on studies involving estrogen receptor modulation and hormone-dependent signaling pathways. It is frequently used in research exploring bone metabolism, breast cancer biology, and endocrine system regulation.
These applications make Bazedoxifene acetate a valuable tool for both mechanistic studies and drug discovery programs targeting hormone-related conditions.
In vitro, Bazedoxifene acetate is commonly used in cell-based assays to evaluate receptor binding and transcriptional activity. It allows researchers to measure changes in gene expression and receptor-mediated signaling in controlled environments.
Such studies help clarify the compound’s selective modulatory effects and support comparison with other estrogen receptor modulators.
In vivo studies of Bazedoxifene acetate have examined its impact on bone density and estrogen-related physiological processes. It has been used in animal models to assess effects on skeletal health and hormone-regulated tissues.
These studies provide insight into pharmacokinetic behavior and systemic responses, contributing to translational research efforts.
The primary biochemical action of Bazedoxifene acetate involves selective modulation of estrogen receptors, influencing gene transcription and cellular responses. Its activity varies depending on tissue type, acting as an antagonist or agonist in different biological contexts.
From a physiological perspective, this selective behavior supports research into hormone balance, bone metabolism, and cancer-related pathways, where precise receptor targeting is essential.
Bazedoxifene acetate offers a well-characterized profile for endocrine research, making it suitable for a wide range of experimental applications. When supplied as EBC-99103, it is supported by quality control and analytical validation, ensuring consistency in laboratory use.
As part of a comprehensive portfolio of bioactive molecules, Bazedoxifene acetate supports advanced investigation of hormone signaling and helps researchers refine experimental approaches in complex biological systems.
SDS
TSE 424 | WAY-TSE 424 | bazedoxifene acetate
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$46
2 mg
$48
5 mg
$49
10 mg
$50
15 mg
$51
20 mg
$52
25 mg
$57
30 mg
$61
35 mg
$69
40 mg
$76
45 mg
$83
50 mg
$90
75 mg
$96
100 mg
$POA
Quantity
1
Total amount
$ 49
TSE 424 | WAY-TSE 424 | bazedoxifene acetate
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:198481-32-2
0